Valneva SE (VALN) EBIT (2021 - 2026)
Valneva SE (VALN) reported EBIT of $27.5 million for Q1 2026, down 42.17% on a YoY basis from $47.6 million in Q1 2025, and up 111.07% sequentially from -$248.8 million in Q4 2025.
Valneva SE (VALN) EBIT (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has 6 years of EBIT data on file, last reported at $27.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 42.17% year-over-year to $27.5 million; the trailing twelve-month figure through Mar 2026 stood at -$129.6 million (down 132.99% YoY), and the FY2025 full-year result was -$95.5 million, down 762.08% from the prior year.
- EBIT rose to $27.5 million in Q1 2026, from -$248.8 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $94.1 million in Q3 2022 to a low of -$248.8 million in Q4 2025.
- A 5-year average of -$26.4 million and a median of $27.5 million in 2026 frame the typical range for EBIT.
- Across the five-year window, EBIT sank 212.28% in 2023 and jumped 298.36% in 2024, its largest moves.
- Tracing VALN's EBIT over 5 years: stood at -$57.5 million in 2022, then slumped by 212.28% to -$179.5 million in 2023, then declined by 6.21% to -$190.7 million in 2024, then plunged by 30.48% to -$248.8 million in 2025, then jumped by 111.07% to $27.5 million in 2026.
- Business Quant data shows VALN's EBIT at $27.5 million in Q1 2026, -$248.8 million in Q4 2025, and $44.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Valneva SE | 811.46 Mn | 688.23 Mn | 5.08 Mn | 27.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.54 Mn |
| Dec 31, 2025 | -248.81 Mn |
| Sep 30, 2025 | 44.48 Mn |
| Jun 30, 2025 | 47.16 Mn |
| Mar 31, 2025 | 47.62 Mn |
| Dec 31, 2024 | -190.69 Mn |
| Sep 30, 2024 | 47.70 Mn |
| Jun 30, 2024 | 39.73 Mn |
| Mar 31, 2024 | 33.99 Mn |
| Dec 31, 2023 | -179.53 Mn |
| Sep 30, 2023 | 44.53 Mn |
| Jun 30, 2023 | -20.03 Mn |
| Mar 31, 2023 | -17.79 Mn |
| Dec 31, 2022 | -57.49 Mn |
| Sep 30, 2022 | 94.09 Mn |
| Jun 30, 2022 | -140.84 Mn |
| Mar 31, 2022 | -20.68 Mn |
| Dec 31, 2021 | 201.58 Mn |
| Sep 30, 2021 | -178.58 Mn |
| Jun 30, 2021 | -66.28 Mn |